The Spectranetics
The Spectranetics Corporation specializes in the development, manufacturing, and distribution of single-use medical devices for minimally invasive cardiovascular procedures. Its portfolio includes laser and aspiration catheters, scoring balloon catheters, and drug-coated balloon catheters, used to cross, prepare, and treat arterial blockages in the legs and heart. Additionally, the company offers products for the removal of pacemaker and defibrillator cardiac leads, and provides laser systems for various cardiovascular procedures. Spectranetics sells its products directly and through distributors worldwide, with a focus on innovation to meet the demands of complex cardiac lead removal and vascular intervention procedures. Headquartered in Colorado Springs, Colorado, the company operates as a subsidiary of Philips Holding USA Inc.
AngioScore
Acquisition in 2014
AngioScore Inc. is engaged in the development, manufacturing, and marketing of medical devices, specifically focusing on the AngioSculpt Scoring Balloon Catheter. This catheter is designed for use in both coronary and peripheral interventional markets, addressing the limitations commonly associated with traditional angioplasty balloon catheters. The AngioSculpt features a semi-compliant balloon combined with a unique nitinol scoring element, enhancing its effectiveness in endovascular therapy. The company's products are aimed at improving the treatment of cardiovascular and vascular diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.